BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garcia-Ruiz C, Conde de la Rosa L, Ribas V, Fernandez-Checa JC. MITOCHONDRIAL CHOLESTEROL AND CANCER. Semin Cancer Biol 2021;73:76-85. [PMID: 32805396 DOI: 10.1016/j.semcancer.2020.07.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chavez-tapia NC, Murúa-beltrán Gall S, Ordoñez-vázquez AL, Nuño-lambarri N, Vidal-cevallos P, Uribe M. Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma. JHC 2022;Volume 9:583-93. [DOI: 10.2147/jhc.s283840] [Reference Citation Analysis]
2 Nguyen MKL, Jose J, Wahba M, Bernaus-esqué M, Hoy AJ, Enrich C, Rentero C, Grewal T. Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance. IJMS 2022;23:7206. [DOI: 10.3390/ijms23137206] [Reference Citation Analysis]
3 Simoni-Nieves A, Salas-Silva S, Chávez-Rodríguez L, Escobedo-Calvario A, Desoteux M, Bucio L, Souza V, Miranda-Labra RU, Muñoz-Espinosa LE, Coulouarn C, Gutiérrez-Ruiz MC, Marquardt JU, Gomez-Quiroz LE. The Consumption of Cholesterol-Enriched Diets Conditions the Development of a Subtype of HCC with High Aggressiveness and Poor Prognosis. Cancers (Basel) 2021;13:1721. [PMID: 33917315 DOI: 10.3390/cancers13071721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Guerra B, Recio C, Aranda-Tavío H, Guerra-Rodríguez M, García-Castellano JM, Fernández-Pérez L. The Mevalonate Pathway, a Metabolic Target in Cancer Therapy. Front Oncol 2021;11:626971. [PMID: 33718197 DOI: 10.3389/fonc.2021.626971] [Cited by in Crossref: 4] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]